2026-01-19 - Analysis Report
### Financial Report for Ventas (VTR)

#### 1. Cumulative Return Analysis
- **Company Overview**: Ventas is a global healthcare and senior living real estate REIT.
- **Cumulative Return of VTR**: 86.66%
- **Cumulative Return of S&P 500 (VOO)**: 82.54%
- **Divergence**: 4.12%

#### Alpha, Beta Analysis
| Year       | CAGR  | MDD   | Alpha | Beta  | Cap(B) |
|------------|-------|-------|-------|-------|-------|
| 2016-2018  | 13.0% | 12.2% | 13.0% | 0.4   | 27.5B |
| 2017-2019  | 3.0%  | 11.1% | -6.0% | 0.2   | 27.1B |
| 2018-2020  | 34.0% | 43.0% | 13.0% | 1.3   | 23.0B |
| 2019-2021  | 1.0%  | 43.0% | -36.0%| 1.4   | 24.0B |
| 2020-2022  | 26.0% | 43.0% | 15.0% | 1.3   | 21.2B |
| 2021-2023  | 40.0% | 18.3% | 24.0% | 0.8   | 23.4B |
| 2022-2024  | 77.0% | 18.3% | 51.0% | 0.7   | 27.7B |
| 2023-2025  | 45.0% | 12.9% | -4.0% | 0.5   | 36.4B |

#### 2. Recent Stock Price Fluctuations
- **Close Price**: $78.45
- **Previous Close**: $76.92
- **5-day SMA**: $76.97
- **20-day SMA**: $77.64
- **60-day SMA**: $77.18
- **Change**: $1.99

#### 3. RSI and PPO Analysis
- **Market Risk Indicator (MRI)**: 0.80 (Medium Investment)
- **RSI**: 43.04
- **PPO**: 0.04
- **Hybrid Signal**: Sell (Shares 80%)
- **Recent Relative Divergence Change**: 0.0
- **7-day Rank Change**: 0
- **7-day Dynamic Expected Return Change**: 0.0
- **Expected Return (%)**: N/A

#### 4. Recent News & Significant Events
- [2026-01-18] A Look At Ventas (VTR) Valuation After Recent Share Price Momentum - simplywall.st (link)
- [2026-01-14] More than 850 senior housing communities: Ventas sets Q4 2025 call date - Stock Titan (link)
- [2026-01-15] Nordea Investment Management AB Boosts Stock Position in Ventas, Inc. $VTR - MarketBeat (link)
- [2026-01-14] How To YieldBoost VTR From 2.5% To 8.3% Using Options - Nasdaq (link)
- [2026-01-17] Ventas' quarterly earnings preview: What you need to know - MSN (link)
- [2026-01-17] Analysts Offer Insights on Real Estate Companies: Ventas (VTR) and Cushman & Wakefield (CWK) - The Globe and Mail (link)

#### 4-2. Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.52 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): 85.65 / 94.00 / 75.00
```

#### 5. Recent Earnings Analysis
| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-10-30 | 0.14 | 1.49 B$  |
| 2025-07-31 | 0.15 | 1.42 B$  |
| 2025-05-01 | 0.11 | 1.36 B$  |
| 2024-10-31 | 0.05 | 1.24 B$  |
| 2025-10-30 | 0.05 | 1.24 B$  |

#### 6. Financial Information
**Revenue and Profitability**
| Quarter     | Revenue | Profit Margin |
|-------------|---------|---------------|
| 2025-09-30  | $1.49B  | 41.58%        |
| 2025-06-30  | $1.42B  | 41.80%        |
| 2025-03-31  | $1.36B  | 42.15%        |
| 2024-12-31  | $1.29B  | 42.42%        |
| 2024-09-30  | $1.24B  | 42.17%        |

**Capital and Profitability**
| Quarter     | Equity  | ROE   |
|-------------|---------|-------|
| 2025-09-30  | $12.36B | 0.53% |
| 2025-06-30  | $11.53B | 0.59% |
| 2025-03-31  | $11.47B | 0.41% |
| 2024-12-31  | $10.77B | 0.53% |
| 2024-09-30  | $9.76B  | 0.20% |

#### 7. Comprehensive Analysis
- Ventas (VTR) shows a cumulative return of 86.66%, outperforming the S&P 500's 82.54%.
- Recent stock price fluctuations indicate a slight increase, with a current price of $78.45.
- Market indicators suggest a medium risk investment with a hybrid sell signal.
- Analyst consensus is a buy with a mean rating of 1.52 and a target price average of $85.65.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.